Author: Calabrò, Luana; Rossi, Giulia; Covre, Alessia; Morra, Aldo; Maio, Michele
Title: COVID and Lung Cancer Cord-id: ss010jjn Document date: 2021_10_22
ID: ss010jjn
Snippet: PURPOSE OF REVIEW: Since the past year, the fast spread of coronavirus disease 2019 (COVID-19) has represented a global health threat, especially for cancer patients, that has required an urgent reorganization of clinical activities. Here, we will critically revise the profound impact that the pandemic has generated in lung cancer patients, as well the most significant challenges that oncologists have to face to maintain the highest possible standards in the management of lung cancer patients in
Document: PURPOSE OF REVIEW: Since the past year, the fast spread of coronavirus disease 2019 (COVID-19) has represented a global health threat, especially for cancer patients, that has required an urgent reorganization of clinical activities. Here, we will critically revise the profound impact that the pandemic has generated in lung cancer patients, as well the most significant challenges that oncologists have to face to maintain the highest possible standards in the management of lung cancer patients in the pandemic era. RECENT FINDINGS: Evidences suggested a higher susceptibility and mortality of lung cancer patients due to COVID-19. The hard management of this patient population has been also due to the potential cross interference of anti-tumor drugs on SARS-Cov-2 infection and to the differential diagnosis between COVID-19 pneumonitis and drug-related pneumonitis. SUMMARY: COVID-19 pandemic has generated a profound reshaping of oncological activities and the development of recommendations by the oncology scientific community to prioritize anti-tumor treatments for lung cancer patients.
Search related documents:
Co phrase search for related documents- aberrant expression and lung carcinoma: 1, 2, 3
- aberrant expression and lung disease: 1
- aberrant expression and lung injury: 1, 2, 3, 4
- active therapy and adaptive immune response: 1
- active therapy and locally advanced: 1
- active therapy and long course: 1
- active therapy and lung cancer: 1, 2, 3, 4, 5, 6, 7
- active therapy and lung cancer sars: 1, 2
- active therapy and lung disease: 1, 2, 3, 4
- active therapy and lung injury: 1, 2, 3
- acute interstitial pneumonitis and locally advanced: 1
- acute interstitial pneumonitis and lung cancer: 1, 2
- acute interstitial pneumonitis and lung cancer sars: 1
- acute interstitial pneumonitis and lung cancer treatment: 1
- acute interstitial pneumonitis and lung disease: 1
- acute interstitial pneumonitis and lung injury: 1, 2, 3
- acute viral infection and adaptive immune response: 1, 2, 3, 4
- acute viral infection and lung alveolar: 1, 2, 3
- acute viral infection and lung cancer: 1
Co phrase search for related documents, hyperlinks ordered by date